Adjuvant therapy of renal cell carcinoma: patient selection and therapeutic options
Open Access
- 11 August 2005
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 96 (4) , 483-488
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- POSTOPERATIVE SURVEILLANCE PROTOCOL FOR PATIENTS WITH LOCALIZED AND LOCALLY ADVANCED RENAL CELL CARCINOMA BASED ON A VALIDATED PROGNOSTIC NOMOGRAM AND RISK GROUP STRATIFICATION SYSTEMJournal of Urology, 2005
- Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal CancerClinical Cancer Research, 2005
- Period Analysis of Prostate Cancer SurvivalJournal of Clinical Oncology, 2005
- Using Protein Expressions to Predict Survival in Clear Cell Renal CarcinomaClinical Cancer Research, 2004
- Erratum for Volume 21, pg. 3972Journal of Clinical Oncology, 2004
- Adjuvant High-Dose Bolus Interleukin-2 for Patients With High-Risk Renal Cell Carcinoma: A Cytokine Working Group Randomized TrialJournal of Clinical Oncology, 2003
- Heat Shock Proteins: Their Role in Urological TumorsJournal of Urology, 2003
- Monoclonal Antibody Therapy for Genitourinary Oncology: Promise for the FutureJournal of Urology, 2002
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and Bacillus Calmette-Guèrin: Five-year results of a prospective randomized studyCancer, 1996